The pharmacy ecosystem is changing at an unprecedented rate. Because of this, financial risks and opportunities are great. Life science companies continue to innovate novel drug therapies, especially within the specialty drug space. Payers rely on actuaries to understand and incorporate the impact of these therapies into insurance product prices. Stakeholders must navigate the complex operational, regulatory, and fiscal pharmacy environment.

Program Goals

  • Gain a foundational understanding of the role of an actuary in a health plan, and specifically in benefit and coverage decisions.
  • Engage in developing actuarial assumptions, modeling and quantitative and qualitative measurement of a market disruption for a mock drug.
  • Explore the Medicare Part D ecosystem and how this impacts a payers expectations during the Medicare Part D bid process.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.